Teva releases Minastrin generic

JERUSALEM — Teva Pharmaceutical Industries on Monday launched an authorized Generic of Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) 1 mg/20 mcg in the United States.

The authorized generic is an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy.

Minastrin 24 Fe, manufactured by Allergan had annual sales of approximately $361 million in the U.S. according to IMS data as of December 2016.